According to Bionomics's latest financial reports and stock price the company's current Operating Margin is -8,326.37%. At the end of 2022 the company had an Operating Margin of -8,326.38%.
Year | Operating Margin | Change |
---|---|---|
2022 | -8,326.38% | |
2020 | -12,915.41% | 4886.35% |
2019 | -259.02% | -62.96% |
2018 | -699.27% | 503.66% |
2017 | -115.84% | -53.31% |
2016 | -248.08% | -4.81% |
2015 | -260.63% | -1364% |
2014 | 20.62% | -103.39% |
2013 | -608.55% | 105.86% |
2012 | -295.61% | -6.9% |
2011 | -317.51% | 15.7% |
2010 | -274.41% | 43.61% |
2009 | -191.09% | -58.16% |
2008 | -456.75% | -52.74% |
2007 | -966.45% | 13.53% |
2006 | -851.26% | -45.69% |
2005 | -1,567.34% | |
2003 | -441.62% | 103.95% |
2002 | -216.54% | -22.49% |
2001 | -279.37% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.